Teva Canada Limited (Teva Canada) announced today that Health Canada has approved an expanded indication for PrAJOVY® ...

More than a billion people worldwide struggle to find relief from the unbearable pain of migraine. But research is leading to ...

A study by Taipei Veterans General Hospital Vice Superintendent Wang Shu-chun (王署君) found about 6.8% of youths aged 12 to 15 in Taiwan experience migraines. The condition can cause severe headaches ...

AbbVie Inc. targets $38B in Skyrizi and Rinvoq sales by 2030, a 3% dividend yield, and 7.7% EPS growth via acquisitions.

Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript February 3, 2026 Pfizer Inc. beats earnings expectations. Reported ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

Low back pain (LBP) is a crucial risk factor for future health decline, affecting quality of life of individuals. Now, researchers have discovered ...

Low back pain (LBP) is one of the most common health problems worldwide, affecting people of all ages and placing a heavy burden on healthcare systems. Many patients experience persistent discomfort ...

Navigating migraine during pregnancy can be challenging. Discover which treatments are safe, plus tips on preconception planning and postpartum care.

In this randomized controlled trial involving pediatric patients, fremanezumab led to greater reductions in the number of migraine days per month versus placebo, consistent with previous trials in ...

A previous version of this story had an incorrect title for Brian Dunkin. He is the chief medical officer of endoscopy at Boston Scientific. The story has been corrected. Millions of Americans have ...